1144P Clinical outcomes of NSCLC patients (pts) who had brain-only metastasis at time of stage IV diagnosis, by presence versus absence of EGFR/ALK mutations

S. Schmid, L.J. Zhan,M. Garcia,S. Cheng,K. Khan,M.T. Chowdhury,A. Sabouhanian,J. Herman, P. Walia,E. Strom, M.C. Brown,D. Patel,W. Xu,F.A. Shepherd,A. Sacher,N. Leighl,P. Bradbury,D. Shultz, G. Liu

Annals of Oncology（2022）

引用 0|浏览16

暂无评分

摘要

Treatment strategies and outcomes in pts with initially brain-only metastatic (m) NSCLC are not well understood. We evaluated strategies/outcomes specifically in such pts by presence or absence of EGFR/ALK mutations.

查看译文

关键词

nsclc patients,metastasis,egfr/alk,clinical outcomes,stage iv diagnosis,brain-only

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要